Plain-English translation of NCT03906253 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing fractionated laser resurfacing—a skin treatment that gently resurfaces the outer layers of skin—to see if it can help prevent actinic keratosis and skin cancer in older adults. Researchers believe this treatment helps aging skin respond better to sun damage and may protect against future skin cancers for years afterward.
As we age, our skin loses its natural ability to repair sun damage, leading to precancerous spots and skin cancers. This study wants to find out if this laser treatment can restore that protective ability and prevent these dangerous skin changes from developing.
You likely qualify if…
You likely don't qualify if…
You would come in for a single day of treatment where one forearm receives the laser resurfacing procedure. Then you would return for follow-up visits at 90 days and every 6 months for 5 years so researchers can track whether new precancerous spots or skin cancers develop on the treated and untreated forearms. The study compares how well the treated side protects against future skin damage compared to the untreated side.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States
Wright State University
Enrollment target
~72 participants
Started
January 2018
Primary completion
December 2028
Age range
60 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Manager, Clinical Research Operations
Wright State University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.